BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2350687)

  • 1. Participation of different brain regions in the anti-narcotic withdrawal action of clonidine in the dependent rat.
    Buccafusco JJ
    Brain Res; 1990 Apr; 513(1):8-14. PubMed ID: 2350687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular changes during morphine withdrawal in the rat: effects of clonidine.
    Buccafusco JJ
    Pharmacol Biochem Behav; 1983 Feb; 18(2):209-15. PubMed ID: 6682228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat.
    Milne B; Cervenko FW; Jhamandas K; Sutak M
    Anesthesiology; 1985 Jan; 62(1):34-8. PubMed ID: 4038443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in rats.
    Buccafusco JJ; Marshall DC; Turner RM
    Life Sci; 1984 Sep; 35(13):1401-8. PubMed ID: 6148677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat.
    Holland LN; Shuster LC; Buccafusco JJ
    Neuropharmacology; 1993 Dec; 32(12):1387-95. PubMed ID: 8152529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
    Pinelli A; Trivulzio S
    J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
    Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
    Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms.
    Buccafusco JJ; Shuster LC
    Brain Res Bull; 1997; 43(3):321-6. PubMed ID: 9227843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraspinal and spinal mediation of naloxone-induced morphine withdrawal in rats.
    Marshall DC; Buccafusco JJ
    Brain Res; 1985 Mar; 329(1-2):131-42. PubMed ID: 4038893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cholinergic neurons and the expression of morphine withdrawal symptoms in the rat.
    Marshall DC; Buccafusco JJ
    J Neurosci; 1987 Mar; 7(3):621-8. PubMed ID: 3559705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clonidine on morphine withdrawal signs in the rat.
    Tseng LF; Loh HH; Wei ET
    Eur J Pharmacol; 1975 Jan; 30(1):93-9. PubMed ID: 1168138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine.
    Rada P; Pothos E; Mark GP; Hoebel BG
    Brain Res; 1991 Oct; 561(2):354-6. PubMed ID: 1802350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
    Rosen MI; McMahon TJ; Hameedi FA; Pearsall HR; Woods SW; Kreek MJ; Kosten TR
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1128-35. PubMed ID: 8786543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat.
    Shearman GT; Lal H; Ursillo RC
    Pharmacol Biochem Behav; 1980 Apr; 12(4):573-5. PubMed ID: 7190295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(13):1129-34. PubMed ID: 8450707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
    Pinelli A; Trivulzio S; Spezia R
    Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous withdrawal in intermittent morphine administration in rats and mice: effect of clonidine coadministration and sex-related differences.
    Allahverdiyev O; Türkmen AZ; Nurten A; Sehirli I; Enginar N
    Turk J Med Sci; 2015; 45(6):1380-9. PubMed ID: 26775398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine.
    Feily A; Abbasi N
    Phytother Res; 2009 Nov; 23(11):1549-52. PubMed ID: 19370548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.